Published in J Infect Dis on December 01, 1992
Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev (1995) 1.73
Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit Care (2002) 1.61
Choice of bacteria in animal models of sepsis. Infect Immun (1993) 1.51
Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect Immun (2006) 1.50
Time course of cytokine levels in sepsis. Intensive Care Med (1995) 1.22
Interleukin-6, gamma interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy. Antimicrob Agents Chemother (1993) 1.01
Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect. Toxins (Basel) (2013) 0.98
Translocation. Incidental phenomenon or true pathology? Ann Surg (1993) 0.90
Reappraisal with meta-analysis of bacteremia, endotoxemia, and mortality in gram-negative sepsis. J Clin Microbiol (1995) 0.87
Concordance of endotoxemia with gram-negative bacteremia in patients with gram-negative sepsis: a meta-analysis. J Clin Microbiol (1994) 0.87
New therapeutic approaches in sepsis: a critical review. Intensive Care Med (1995) 0.85
Does gram-negative bacteraemia occur without endotoxaemia? A meta-analysis using hierarchical summary ROC curves. Eur J Clin Microbiol Infect Dis (2009) 0.84
Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders. Crit Care (2012) 0.77
A model for rational introduction of new and expensive medicines. Postgrad Med J (1995) 0.75
The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes. Immunology (1995) 0.75
Bacteremia, endotoxemia, and mortality in gram-negative sepsis: a reappraisal. J Infect Dis (1993) 0.75
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med (1998) 13.94
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med (1995) 10.29
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med (1991) 9.99
Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med (1999) 6.24
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis (1987) 5.63
Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med (1992) 5.48
A look into the nature and causes of human errors in the intensive care unit. Crit Care Med (1995) 5.14
Clinical antecedents to in-hospital cardiopulmonary arrest. Chest (1990) 4.94
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39
The ACCP-SCCM consensus conference on sepsis and organ failure. Chest (1992) 4.35
Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis. Ann Intern Med (1992) 3.74
Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Arch Intern Med (1988) 3.74
Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health (1983) 3.33
Comparative safety of antiepileptic drugs during pregnancy. Neurology (2012) 3.32
Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med (1997) 3.26
Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol (1994) 3.22
Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med (1994) 3.09
Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet (2001) 2.94
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88
Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med (1990) 2.82
Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology (2005) 2.80
Definitions for sepsis and organ failure. Crit Care Med (1992) 2.69
Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet (1988) 2.67
Controlled comparison of amikacin and gentamicin. N Engl J Med (1977) 2.62
Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med (1984) 2.54
Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med (1980) 2.51
The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol (1988) 2.51
Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM). Intensive Care Med (2012) 2.49
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis (1984) 2.44
A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med (1993) 2.39
The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med (1984) 2.37
Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood (1990) 2.33
Plasma cortisol levels in patients with septic shock. Crit Care Med (1990) 2.33
Evaluation of preoperative biliary drainage in the surgical management of pancreatic head carcinoma. Acta Chir Scand (1988) 2.33
High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med (1987) 2.32
Do mussels take wooden steps to deep-sea vents? Nature (2000) 2.32
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology (2000) 2.21
Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol (2001) 2.20
Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet (1997) 2.20
Limitations of compression ultrasound for the detection of symptomless postoperative deep vein thrombosis. Lancet (1994) 2.18
Evaluation of Institutional Review Board review and informed consent in publications of human research in critical care medicine. Crit Care Med (1998) 2.14
Procoagulant and proinflammatory activity in acute coronary syndromes. Cardiovasc Res (1998) 2.12
Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med (2001) 2.12
Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside. Lancet (1978) 2.10
[Atherosclerosis partly due to local vasculitis]. Ned Tijdschr Geneeskd (1994) 2.05
Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology (2008) 2.04
How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03
[Optimal treatment with oral anticoagulants]. Ned Tijdschr Geneeskd (1996) 2.03
Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis (2000) 2.00
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg (1998) 1.95
Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol (2001) 1.95
Experimental verocytotoxemia in rabbits. Infect Immun (1992) 1.94
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut (1999) 1.94
Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA (1993) 1.88
Bronchocentric mycosis occurring in transplant recipients. Chest (1989) 1.84
Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am (1999) 1.82
Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation (1992) 1.78
Robotic mitral valve surgery: a United States multicenter trial. J Thorac Cardiovasc Surg (2005) 1.77
Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med (1990) 1.76
Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet (1994) 1.76
Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet (1992) 1.73
Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med (1996) 1.70
Bacterial translocation in multiple organ failure: cause or epiphenomenon still unproven. Br J Surg (1997) 1.69
Proinflammatory effects of IL-10 during human endotoxemia. J Immunol (2000) 1.69
Influence of hypothermia, barbiturate therapy, and intracranial pressure monitoring on morbidity and mortality after near-drowning. Crit Care Med (1986) 1.66
Application of SOFA score to trauma patients. Sequential Organ Failure Assessment. Intensive Care Med (1999) 1.66
Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg (2000) 1.65
A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The Multicenter High-Dose Epinephrine Study Group. N Engl J Med (1992) 1.64
Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med (1994) 1.64
Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits. Nat Med (1999) 1.64
Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg (1995) 1.63
Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med (1994) 1.63
Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg (1998) 1.63
Misclassification in epidemiologic studies of adverse drug reactions using large managerial data bases. Am J Prev Med (1988) 1.62
The value of lung scintigraphy in the diagnosis of pulmonary embolism. Eur J Nucl Med (1993) 1.61
Reliable rapid blood test for the exclusion of venous thromboembolism in symptomatic outpatients. Thromb Haemost (1996) 1.61
Estimating time to conduct a meta-analysis from number of citations retrieved. JAMA (1999) 1.61
Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy (2007) 1.60
Adverse drug reactions in hospitalized patients: A critique of a meta-analysis. MedGenMed (2000) 1.59
Intestinal endotoxemia. Clinical significance. Gastroenterology (1988) 1.59
Clinical variability within Brachmann-de Lange syndrome: a proposed classification system. Am J Med Genet (1993) 1.59
Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg (1998) 1.58
Effect of first-responder automated defibrillation on time to therapeutic interventions during out-of-hospital cardiac arrest. The Multicenter High Dose Epinephrine Study Group. Ann Emerg Med (1993) 1.58
Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med (1984) 1.57
Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun (1994) 1.57
Pressure sores among hospitalized patients. Ann Intern Med (1986) 1.56
Antigen biological activity ratio for factor VIII in late pregnancy. Lancet (1973) 1.54
A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology (1997) 1.54
The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA (1996) 1.53
Living related donation in lung transplantation. Ethical considerations. Arch Intern Med (1995) 1.53
Inherited complement deficiency in children surviving fulminant meningococcal septic shock. Eur J Pediatr (1995) 1.53
Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis (1984) 1.52
Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res (1997) 1.52
Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis. J Infect Dis (1999) 1.51